v3.25.2
Segment Information
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segment Information

15. Segment Information

Tivic Health is a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health. Tivic’s bioelectronic program is developing non-invasive medical devices that optimize key stimulation parameters for the vagus nerve. Tivic’s new biopharma program is focused on advancing its first drug product candidate, Entolimod, into manufacturing, conducting process validation utilizing the output of such manufacturing, filing the associated Biologics License Application with the FDA, with the intent to sell the biologic compounds either inside or outside of the United States. Tivic also has an FDA-approved over-the-counter device, ClearUP, that treats sinus pain and pressure, for which it is actively pursuing various monetization strategies. Revenue is derived from sales of the Company’s first commercial product, ClearUP. To date, the Company manages the business activities as a single operating segment. Tivics Chief Executive Officer is the CODM. The CODM utilizes the Companys long-term plan, which includes product development roadmaps and long-term financial models, as key input to resource allocation. The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using factors such as gross margin, operating expenses, loss from operations and net loss.

Significant expenses within loss from operations, as well as within net loss, include costs of revenue, research and development, selling and marketing and general and administrative expenses, which are each separately presented on the Company’s Statements of Operations. Other segment items within net loss include interest income.

During the three and six months ended June 30, 2025 and 2024, all revenue was domestic revenue. To date, the Company has not sold its product outside of the United States.

The Company’s long-lived assets consist primarily of property and equipment, all of which are located in the United States.